News | July 11, 2023
Briefs: Link Pharma Chem and Zydus
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
Approval to dramatically change CAR-T therapies landscape
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
Marketing Authorization replaces conditional Marketing Authorization and is first for Novavax in the EU
The company has submitted marketing authorization applications for mRNA-1345 with the European Medicines Agency (EMA), Swissmedic in Switzerland, and the Therapeutic Goods Administration (TGA) in Australia
Advances clinical research capabilities with leading regulatory grade registries platform
_256_384.jpg)
The collaboration aims to raise awareness about eye cancer, provide medical and surgical treatment support to children and supply nutritional supplements to aid in their faster recovery.
With close to 30-40 basic screening tests available, the unit encompasses all the essential parameters typically covered in annual health check-ups
Especially valuable for young patients with multiple blocks & underlying conditions that may render angioplasty procedures with drug-eluting stents ineffective
Subscribe To Our Newsletter & Stay Updated
